Baha' Sharaf (Baha Sharaf)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Psychometric Properties

Metastatic Breast Cancer

Top Venues

Breast cancer (Dove Medical Press)

Cancer management and research

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Ramiz Abu-Hijlih, Baha' Sharaf, Samer Salah, Hira Bani Hani, Mohammad Alqaisieh, Abdulla M Alzibdeh, Layan Ababneh, Suleiman Mahafdah, Hikmat Abdel-Razeq
Germline Genetic Mutations in Adult Patients with Sarcoma: Insight into the Middle East Genetic Landscape. Cancers 16 (9) (2024)
Hikmat Abdel-Razeq, Hira Bani Hani, Baha' Sharaf, Faris Tamimi, Hanan Khalil, Areej Abu Sheikha, Mais Alkyam, Sarah Abdel-Razeq, Tala Ghatasheh, Tala Radaideh, Suhaib Khater
Patterns and Frequency of Pathogenic Germline Mutations among Patients with Newly-Diagnosed Endometrial Cancer: The Jordanian Exploratory Cancer Genetics (Jo-ECAG) Endometrial Study. Cancers 16 (14) (2024)
Akram N Al-Ibraheem, Ahmed Saad Abdlkadir, Deya' Aldeen Sweedat, Stephan Maus, Ula Al-Rasheed, Samer Salah, Fadi Khriesh, Diyaa Juaidi, Dina Abu Dayek, Feras Istatieh, Farah Anwar, Aisha Asrawi, Alaa Abufara, Mohammad Al-Rwashdeh, Ramiz Abu-Hijlih, Baha' Sharaf, Rami Ghanem, Hikmat Abdel-Razeq, Asem H Mansour
From Despair to Hope: First Arabic Experience of 177 Lu-PSMA and 161 Tb-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer. Cancers 16 (11) (2024)
Ramiz Abu-Hijlih, Baha' Sharaf, Samer Salah, Hira Bani Hani, Mohammad Alqaisieh, Abdulla M Alzibdeh, Layan Ababneh, Suleiman Mahafdah, Hikmat Abdel-Razeq
Germline Genetic Mutations in Adult Patients with Sarcoma: Insight into the Middle East Genetic Landscape. Cancers 16 (9) (2024)
Hikmat Abdel-Razeq, Baha' Sharaf, Hira Bani Hani, Ramiz Abu-Hijlih, Mais Alkyam, Khansa Al-Azzam, Shatha Elemian, Abdelghani Tbakhi, Areej Al-Atary, Rachel E Ellsworth, Emily M Russell, Edward D Esplin, Malek Horani, Zeidan Zeidan, Abdulla Alzibdeh, Brandie H Leach, Sarah M Nielsen, Robert Luke Nussbaum
Implementation of Universal Pan-Cancer Germline Genetic Testing in an Arab Population: The Jordanian Exploratory Cancer Genetics Study. JCO global oncology 10 (2024)
Hikmat Abdel-Razeq, Hira Bani Hani, Baha' Sharaf, Faris Tamimi, Hanan Khalil, Areej Abu Sheikha, Mais Alkyam, Sarah Abdel-Razeq, Tala Ghatasheh, Tala Radaideh, Suhaib Khater
Patterns and Frequency of Pathogenic Germline Mutations among Patients with Newly-Diagnosed Endometrial Cancer: The Jordanian Exploratory Cancer Genetics (Jo-ECAG) Endometrial Study. Cancers 16 (14) (2024)
Akram N Al-Ibraheem, Ahmed Saad Abdlkadir, Deya' Aldeen Sweedat, Stephan Maus, Ula Al-Rasheed, Samer Salah, Fadi Khriesh, Diyaa Juaidi, Dina Abu Dayek, Feras Istatieh, Farah Anwar, Aisha Asrawi, Alaa Abufara, Mohammad Al-Rwashdeh, Ramiz Abu-Hijlih, Baha' Sharaf, Rami Ghanem, Hikmat Abdel-Razeq, Asem H Mansour
From Despair to Hope: First Arabic Experience of 177 Lu-PSMA and 161 Tb-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer. Cancers 16 (11) (2024)
Hikmat Abdel-Razeq, Hira Bani Hani, Baha' Sharaf, Faris Tamimi, Hanan Khalil, Areej Abu Sheikha, Mais Alkyam, Sarah Abdel-Razeq, Tala Ghatasheh, Tala Radaideh, Suhaib Khater
Patterns and Frequency of Pathogenic Germline Mutations among Patients with Newly-Diagnosed Endometrial Cancer: The Jordanian Exploratory Cancer Genetics (Jo-ECAG) Endometrial Study. Cancers 16 (14) (2024)
Baha' Sharaf, Hala Abu-Fares, Faris Tamimi, Suhaib Al-Sawajneh, Osama Salama, Rand Daoud, Abdulrahman A Alhajahjeh, Sawsan Al-Lababidi, Hikmat Abdel-Razeq
Differences in Treatment Outcomes Between Patients with HER2-Low versus HER2-Zero, Hormone Receptor-Positive Advanced-Stage Breast Cancer Treated with Ribociclib. Breast cancer (Dove Medical Press) 15 (2023)
Hikmat Abdel-Razeq, Lama Abujamous, Khansa Al-Azzam, Hala Abu-Fares, Hira Bani Hani, Mais Alkyam, Baha' Sharaf, Shatha Elemian, Faris Tamimi, Fawzi Abuhijla, Sarah Edaily, Osama Salama, Hazem Abdulelah, Rand Daoud, Mohammad Abubaker, Areej Al-Atary
Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer. Breast cancer (Dove Medical Press) 15 (2023)
Hikmat Abdel-Razeq, Lama Abujamous, Khansa Al-Azzam, Hala Abu-Fares, Hira Bani Hani, Mais Alkyam, Baha' Sharaf, Shatha Elemian, Faris Tamimi, Fawzi Abuhijla, Sarah Edaily, Osama Salama, Hazem Abdulelah, Rand Daoud, Mohammad Abubaker, Areej Al-Atary
Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer. Breast cancer (Dove Medical Press) 15 (2023)
Baha' Sharaf, Rama AlMasri, Nayef Abdel-Razeq, Osama Salama, Ibrahim Hamad, Mahmoud Abu Nasser, Hikmat Abdel-Razeq
Vitiligo-Like Lesions in a Patient with Metastatic Breast Cancer Treated with Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor: A Case Report and Literature Review. Clinical, cosmetic and investigational dermatology 15 (2022)
Hikmat Abdel-Razeq, Baha' Sharaf, Rama AlMasri, Rashid Abdel-Razeq, Faris Tamimi, Omar Khader, Osama Salama, Mahmoud Abu Nasser, Sarah Edaily, Hazem Abdulelah
Thromboembolic Events in Patients with HER2-Negative, Hormone Receptor-Positive, Metastatic Breast Cancer Treated with Ribociclib Combined with Letrozole or Fulvestrant: A Real-World Data. Cancer management and research 14 (2022)
Hikmat Abdel-Razeq, Baha' Sharaf
Expanding the Clinical Use of CDK4/6 Inhibitors in the Treatment of Hormone Receptor-Positive, HER2-Negative Breast Cancer from Metastatic Setting to Adjuvant Setting. Drug design, development and therapy 16 (2022)
Rozan Alfar, Nazmi Kamal, Rashid Abdel Razeq, Zaid Omari, Rayan Bater, Baha' Sharaf
A Durable Response of Primary Advanced Colonic Plasmacytoma Using a Combination of Surgical Resection and Adjuvant Bortezomib: A Case Report and Literature Review. OncoTargets and therapy 15 (2022)
Hikmat Abdel-Razeq, Faris Tamimi, Nayef Abdel-Razeq, Maryam El-Atrash, Baha' Sharaf, Rawan Mustafa, Razan Mansour, Rayan Bater
Late presentation and suboptimal treatment of breast cancer among Syrian refugees: a retrospective study. The Journal of international medical research 49 (5) (2021)